Amphastar's Chinese subsidiary, Amphastar Nanjing Pharmaceuticals, Co., Ltd. ('ANP'), currently has multiple Drug Master Files ('DMFs'), on file with the FDA and is developing several additional DMFs.

Only 14.5% of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen ...

Improved inhalers are now available to help control asthma and treat sudden attacks, but a new study shows that hard ...

The FDA determined that Amphastar's albuterol is bioequivalent and therapeutically equivalent to Teva Respiratory LLC's ProAir ® HFA (albuterol sulfate) Inhalation Aerosol. Amphastar's CEO and ...

However, while the market for albuterol sulfate inhalation products is substantial, with sales around $1.7 billion, it is also highly competitive with multiple existing products, both branded and ...

This plan should outline daily management and how to handle worsening symptoms. Carry rescue inhaler: Always have a rescue ...

Dia’s children received treatment at the Children’s Hospital of Philadelphia, where doctors were able to provide medications ...

Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler ...

Objectives Continuous albuterol nebulization is generally administered at 2.5–20 mg/hr at most centers. We examined the effect of high-dose (75 or 150 mg/hr) albuterol on clinical variables in ...

There are two types of prescription asthma medicines: quick-relief and long-term control.

With drug shortages at an all-time high, the Senate Finance Committee wants to create a new program to incentivize improved ...